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Abstract
Background: Pulmonary rehabilitation (PR) and self-management (SM) support programmes are effective in the
management of patients with chronic obstructive pulmonary disease (COPD), but these interventions are not
widely implemented in routine care. One reason may be poor patient participation and retention. We conducted a
systematic review to determine a true estimate of participation and dropout rates in research studies of these
interventions.
Methods: Studies were identified from eight electronic databases including MEDLINE, UK Clinical Trial Register,
Cochrane library, and reference lists of identified studies. Controlled clinical trial studies of structured SM, PR and
health education (HE) programmes for COPD were included. Data extraction included ‘participant flow’ data using
the Consolidated Standards of Reporting Trials (CONSORT) statement and its extension to pragmatic trials. Patient
‘participation rates’ (study participation rate (SPR), study dropout rate (SDR) and intervention dropout rate (IDR))
were calculated using prior participation definitions consistent with CONSORT. Random effects logistic regression
analysis was conducted to examine effects of four key study characteristics (group vs. individual treatment, year of
publication, study quality and exercise vs. non-exercise) on participation rates.
Results: Fifty-six quantitative studies (51 randomised controlled trials, three quasi-experimental and two before-after
studies) evaluated PR (n = 31), SM (n = 21) and HE (n = 4) programmes. Reports of participant flow were generally
incomplete; ‘numbers of potential participants identified’ were only available for 16%, and ‘numbers assessed for
eligibility’ for only 39% of studies. Although ‘numbers eligible’ were better reported (77%), we were unable to
calculate SPR for 23% of studies. Overall we found ‘participation rates’ for studies (n = 43) were higher than previous
reports; only 19% of studies had less than 50% SPR and just over one-third (34%) had a SPR of 100%; SDR and IDR
were less than or equal to 30% for around 93% of studies. There was no evidence of effects of study characteristics
on participation rates.
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Conclusion: Unlike previous reports, we found high participation and low dropout rates in studies of PR or SM
support for COPD. Previous studies adopted different participation definitions; some reported proportions without
stating definitions clearly, obscuring whether proportions referred to the study or the intervention. Clear, uniform
definitions of patient participation in studies are needed to better inform the wider implementation of effective
interventions.
Keywords: Patient participation, Patient dropouts, Randomised controlled trial, Controlled clinical trial, Chronic
obstructive pulmonary disease, Self-care, Self-management
Background
Chronic obstructive pulmonary disease (COPD) is a large
and increasing public health problem. The disease is
expected to be the third leading cause of death by 2020
[1], and is already the most costly respiratory disease in
Europe, estimated at €38.7 billion annually [2]. In the UK,
COPD affects 2.8 million people although only 0.8 million
are diagnosed with the condition [3]. COPD is an irrevers-
ible, potentially disabling, lung disease characterised by
fatigue and breathlessness and is associated with episodic
‘exacerbations’ [4,5] that lead to unscheduled health care
[6]. An individual with COPD may experience significant
functional and psychological limitations disrupting their
normal routine and further preventing adherence to med-
ical regimes, dietary changes, exercise and smoking cessa-
tion, which can further worsen the condition [3].
Pharmacological treatment only constitutes part of
COPD care. Non-pharmacological interventions, such as
pulmonary rehabilitation (PR) including patient education,
exercise training, psychosocial support and nutritional
intervention complement pharmacological therapy [7].
Self-management (SM) programmes have been promoted
as another non-pharmacological intervention for helping
people with chronic conditions [8]. Self-management
refers to an ‘individual’s ability to manage symptoms,
treatment, physical and psychosocial consequences and
lifestyle changes inherent in living with a chronic condi-
tion. Efficacious self-management encompasses ability to
monitor one’s condition and to effect the cognitive, behav-
ioural and emotional responses necessary to maintain a
satisfactory quality of life’ [9]. The aim of a PR programme
is to reduce symptoms, improve functional performance,
increase participation and reduce health care costs [10].
Using Bourbeau’s [11] definition, SM programmes are
aimed at teaching the skills needed to perform a specific
medical regimen and to achieve health behaviour modifi-
cation. National health policy guidelines and charities
strongly support and recommend the delivery of PR, and
provision of SM education and support to help patients
with COPD to better manage their condition [3,6] and re-
duce cost to health services. There is a huge need amongst
patients for more education on the disease, management
of breathlessness and exacerbations [3,12].
Despite this, a large number of people are unable to
access these interventions [13,14]. Although there is evi-
dence of considerable benefit from PR [14,15], only 1 to
2% of patients are able to access PR programmes because
of patient factors, lack of referral from primary care prac-
titioners and lack of infrastructure for provision of PR
[14]. In a recent review Bjoernshave [15] questioned
whether this benefit could be extrapolated to the entire
PR target population as the patients in studies (including
26 articles) were not representative of the target popula-
tions. There is also limited implementation of SM pro-
grammes for COPD patients in practice. This may be
because of the limited evidence of effectiveness of studies
of SM programmes for COPD patients [13,16]. Effing’s
review [16] noted that synthesising evidence of effective-
ness of SM from studies was difficult due to heterogeneity
in interventions, COPD populations, follow-up times and
outcome measures. Another reason for lack of implemen-
tation could be the poor patient participation and re-
tention frequently reported in the literature on such
interventions [6]. Reduced patient participation or high at-
trition in studies of PR or SM programmes for COPD
patients may affect the generalisability of the study find-
ings to the target population.
There are varied reports of poor participation and high
dropout rates amongst studies. Studies report that only
about 34% of participants attend after being referred to
PR [17] and uptake figures of between 33% and 39%
have been reported from COPD outpatient clinics [18].
A recent review (including 11 articles) [19] reported that
the proportion of referred participants who failed to
attend PR at all ranged from 8.3% to 49.6%, and the pro-
portion of PR dropouts ranged from 9.7% to 31.8%. Our
own study of a COPD disease-specific SM programme
[20] identified poor study participation (only 23%). Attri-
tion may also be a problem but only one study out of four-
teen in a review [16] of COPD SM education reported a
dropout rate (30.4%).
Furthermore, we found large discrepancies between
our calculation of study participation rates in some stud-
ies [21-23] and those reported by other authors [24,25].
Other studies report participation rates in interventions
based on different stages of participant flow before
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recruitment, for example, participation rates calculated
from numbers referred into the study [17] or from the
numbers screened for the study [26]. In addition, it is un-
clear from some studies [18,24] which level of participant
flow was used to calculate the participation or dropout
rate and whether the proportion reported refers to the
study or the intervention. This lack of uniformity or clarity
all leads to further confusion about actual patient partici-
pation rates in studies and interventions.
To address the apparent problem of poor participation
and retention, and to identify ways it could be improved,
we undertook a systematic review to identify actual levels
of participation and attrition reported in randomised and
non-randomised studies evaluating non-pharmacological
interventions providing self-management support to
COPD patients. We hypothesised that the following study
characteristics, recruitment process, patient characteris-
tics, intervention characteristics and study quality may in-
fluence study participation rates and used random effects
logistic regression analysis to explore this.
Methods
The search
A comprehensive search strategy was developed from
other SM systematic reviews (COPD SM education, up-
take of cardiac rehabilitation, SM in musculoskeletal
pain) [8,16,27,28], MeSH headings and free text words
were used. Relevant studies were identified from search-
ing eight electronic biomedical science databases, and
UK Clinical Trial Research registers (1984 to January
2011). We also searched the Cochrane library for sys-
tematic and meta-analysis reviews. The reference lists of
all identified reviews, and published and unpublished
grey reports by organisations that develop and deliver
SM programmes for COPD patients in the UK were
examined for relevant studies. Only English language
papers were included. Additional file 1 presents details
on the search strategy and the terms searched.
Study selection criteria
We included all randomised controlled trials (RCTs),
as well as non-randomised studies including before-
after studies. Interventions included structured self-
management (SM) programmes, pulmonary rehabilita-
tion (PR) programmes, self-care (SC) programmes and
health education (HE) programmes for adults with
COPD. Interventions could be either group-based or tar-
geted at individuals and conducted in any setting, for ex-
ample, outpatients, inpatients, participant’s home, GP
surgery, community, or remote (web-based or telephone)
or a combination of these settings. Intervention delivery
could be by a health professional, or a trained lay person
or both. Conference abstracts, surveys and interventions
that only included exercise and only SM plans or action
plans were excluded.
We obtained full papers of studies identified as poten-
tially eligible based on titles and abstracts. The full copies
of the potentially eligible papers were obtained to assess
whether the studies met the pre-specified inclusion cri-
teria. If additional information was needed, we contacted
the corresponding authors of the study.
Definitions of participation
For the purpose of the review, we adopted the following
definitions (Figure 1):
 ‘Study participation’- eligible patients taking part in
a study of pulmonary rehabilitation (PR) or self-
management (SM) or health education (HE)
intervention and ‘study participants’ - patients that
take part in the study.
 ‘Study non-participation’- not taking part in a study
of PR or SM or HE intervention and ‘study non-
participants’ - patients who do not take part in the
study.
 The ‘study participant’ in the intervention arm of
the study can be subdivided into an ‘attender’ - one
who is exposed to at least part of the intervention
(for example, attends at least one session) and a
‘non-attender’ - one who is not exposed to any part
of the intervention (for example, does not attend
any sessions of the intervention).
 The ‘attenders’ can be further divided into
‘intervention dropouts’ - those who drop out from
the intervention and ‘intervention completers’ -
those who complete the intervention.
 ‘Study completer’ - A ‘non-attender’, ‘intervention
dropout’ or ‘intervention completer’ who completes
the study.
 ‘Study dropout’ - A ‘non-attender’, ‘intervention
dropout’ or ‘intervention completer’ who withdraws
or is lost to follow-up from the study.
Quality assessment
We included studies of any quality since we were inter-
ested in examining whether higher participation rates
tended to be reported in higher quality studies. We
appraised the quality of both randomised and non-
randomised (including before-after) studies using the cri-
teria generated by Downs and Black [29]. The Downs
and Black checklist for quality assessment was selected as
it has been developed to use with both randomised and
non-randomised studies and is recommended as being
suitable for use in systematic reviews [30,31]. Validity and
reliability on the original version of the checklist was
conducted by experienced epidemiologists and statisti-
cians and a revised version produced [29,31]. Further
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assessment of the revised checklist showed that Quality
Index had high internal consistency, good test-retest
(r = 0.88) and inter-rater (r = 0.75) reliability and good
face and criterion validity (0.90) [29].
The checklist allows an overall score for study quality
to be reported as well as scores for each of the subscales.
The question on power was simplified to a simple check
whether the study had conducted a statistical power cal-
culation. The maximum score achievable for each of the
subscales was: 11 for reporting, 3 for external validity
(an area which has been ignored in all checklists of RCTs),
7 for internal validity - bias in the measurement of the
intervention and outcomes, and 6 for internal validity -
confounding (selection bias), totalling to maximum score
of 27.
Data extraction
A data extraction form was developed and piloted for par-
ticular questions to be addressed by the review, and final
versions were used to compile summary tables of the data
and quality classification. Data extraction included study
characteristics (study design, study setting, study eligibility
criteria, recruitment process), population characteristics,
intervention characteristics, definition of intervention
completion, and study outcomes that included participa-
tion data.
The patient participation data (before and after recruit-
ment) was extracted from studies by referring to the
Consolidated Standards of Reporting Trials (CONSORT)
participant flow diagram [32] and the checklist suggested
by extension of the CONSORT statement for reporting
of pragmatic trials [33]. We extracted the following data,
‘numbers of potential participants identified’ ‘numbers
assessed for eligibility’, ‘numbers eligible’a, ‘numbers
included (and randomised or not randomised)’ to all inter-
vention groups, ‘numbers received allocated intervention’,
‘numbers did not receive allocated intervention’, ‘numbers
lost to follow-up’, ‘numbers discontinued intervention’, and
‘numbers analysed for the primary outcomes’.
A second reviewer checked extraction and calculation
of participation rate data from 10% of the studies
sampled at random using a web-based random integer
generator [34].
Data analysis
Calculation of patient ‘participation rates’ from the
extracted participation data was based on the adopted
definitions (Figure 2). The study participation rate (SPR)
was calculated based on ‘numbers included in study’
divided by ‘numbers eligible’. This method of calculation
for SPR is consistent with wording used in extension of
the CONSORT statement for reporting of pragmatic
trials ‘. . . numbers were eligible for study of whom (%)
agreed to participate’ [33]. Glasgow [35] also recom-
mended expanding the criteria in the original CONSORT
statement to include eight items on external validity,
one of which was ‘report the participation rate among
those eligible’.
For studies that reported both the number of eligible
people and the number who were finally included, we
determined participation rate with a 95% confidence inter-
val calculated using a score method with a continuity
‘Non-attenders’ or 
‘Programme 
dropouts’ or 
‘Programme 
completers’ may 
also drop out from 
the study to 
become Study 
dropouts
Eligible patients invited to a study 
of PR, SM or HE intervention 
Patients willing to take part and 
recruited - Study participants
Programme completers complete 
the study – Study completers
Patients not willing to take part and 
not recruited – Study non-
participants 
Study participants attend 
intervention (e.g. comprising of 7 
sessions) - Attenders
Attenders complete the programme 
e.g. all 7 sessions – Programme 
completers
Participants not willing to attend 
intervention at all - Non-attenders
Participants dropped out e.g. after 
3 sessions – Programme 
dropouts 
Figure 1 Illustration of patient participation definitions.
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correction [36]. We used random effects logistic regres-
sion, with participation of each individual as a binary out-
come and a random effect of study, to estimate the effects
of different study characteristics on participation rates.
This amounts to a meta-regression of study results, and
allows studies to be included even if their estimated par-
ticipation rate is 100%.
Because of the relatively small number of studies with
complete data, we chose to limit ourselves to looking at
four study characteristics: year of publication (linear effect
per year), quality score (linear effect per scale point), exer-
cise vs. non-exercise intervention, and group vs. individual
treatment (divided into three categories: individual, com-
bined group and individual, and group). Only studies with
complete data were included. There was heterogeneity be-
tween studies in COPD severity, but this variable was in-
consistently reported and difficult to categorise, so was
not selected for inclusion. Results are reported as adjusted
odds ratio from a multivariable regression model includ-
ing all four study characteristics.
Comparisons of what was reported by studies before
and after publication of the CONSORT guidelines were
made using chi-squared tests (or Fisher’s exact test
where any expected frequency was <5).
Results
We identified 3828 studies from the database search and
13 additional studies from other sources (Figure 3). After
screening, 56 quantitative studies met our inclusion cri-
teria, 51 RCTs, three quasi-experimental studies and two
before-after studies. Thirty-one studies evaluated PR
programmes, twenty-one evaluated SM programmes,
and four studies evaluated HE programmes.
Eligible patients invited to a study  
Patients included and randomised  
Participants assigned to 
intervention arm  
Participants complete 
intervention 
Participants dropout 
or discontinue 
intervention  
Patients are ineligible and do 
not take part for various 
reasons  
Participants assigned to 
control arm  
Participants complete study or 
numbers analysed 
Participants dropout (withdraw 
or loss of follow up) from study 
Participants dropout (withdraw or 
loss of follow up from study  
Calculation of participation rates: 
Study participation rate (SPR) = numbers included (randomised and non-randomised) in study   X 100 
numbers eligible for study  
Study completion rate (SCR) = numbers completed (all groups) study   X 100 
numbers included in study 
Study dropout rate (SDR) = numbers dropped out (all groups) from study   X 100 
numbers included in study 
Proportion assigned to intervention arm (AIA) = numbers assigned to intervention group    X 100 
numbers included in study 
Intervention completion rate (ICR) = numbers complete intervention    X 100 
numbers assigned to intervention group 
Intervention dropout rate (IDR) = numbers dropout of intervention    X 100 
numbers assigned to intervention group 
Figure 2 Calculation of participation rates.
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Study quality was variable. The overall quality of study
reporting was good (9.9), external validity was low (1.3),
internal validity was better amongst studies but, more
bias was present in selection of study subjects (3.6) in
comparison to bias in the measurement of the interven-
tion and outcome (4.8). Less than half of the studies had
conducted a power calculation. There was no clear pat-
tern observed from the quality assessment that high
quality studies had higher participation rates. The sec-
ond reviewer checked a randomly selected 10% of data
extractions and there was 100% agreement between the
two reviewers.
Reporting of participation data and calculation of
participation rate
Additional file 2 provides information on patient par-
ticipant flow (‘number of potential participants identi-
fied’, ‘numbers assessed for eligibility’, ‘numbers eligible’
for study, ‘numbers included (randomised or non-
randomised)’ to all intervention groups, ‘numbers lost
to follow-up’, and ‘numbers discontinued intervention’)
and patient ‘participation rates’ - study participation
rate (SPR), study dropout rate (SDR) and intervention
dropout rate (IDR) by interventions of interest. Partici-
pant flow was poorly reported in all studies. Only nine
Records identified through database 
searching
(n = 3828)
Sc
re
en
in
g
In
cl
ud
ed
El
ig
ib
ili
ty
Id
en
tif
ic
at
io
n Additional records identified through 
other sources
(n = 13)
Records after duplicates removed
(n = 3003+13)
Records screened
(n = 96+13)
Records excluded (n = 2907)
Excluded on:
Topic or Intervention 
(n=1379)
Population (n=1069)
Study design (n=164)
Excluded for other reasons:
No abstract available (n=82)
Duplicate (n=188)
Non-English language 
(n=10)
Study setting (n=11)
Full papers could not e 
obtained (n=4)
Full-text articles assessed for 
eligibility
(n = 49+13)
Full-text articles excluded, with 
reasons
(n = 47)
Systematic reviews (n=14)
Topic or Intervention (n= 
15)
Study design (n= 3)
Population (n= 1)
Not primary study (n= 3)
Interim results (n= 3)
Same sample (n=8)
Studies included in 
qualitative synthesis
(n = 6)
Studies included in mixed-methods review
Quantitative n=56
Qualitative n= 6
(n = 62)
Duplicates removed (n = 825)
Figure 3 PRISMA flowchart showing process of search results for COPD studies.
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(16%) studies reported ‘numbers of potential partici-
pants identified’ (4/31 PR, 4/21 SM and 1/4 HE) and
twenty-two (39%) studies reported ‘numbers assessed
for eligibility’ (12 PR and 10 SM). ‘Numbers eligible’ by
studies was better reported, 43 (77%) studies, (21 PR, 19
SM and 3 HE). Fifty-six studies reported ‘numbers
included (both randomised and non-randomised)’ in
study, out of five non-randomised studies, two were
before-after studies without a control group. Only seven
(13%) studies recorded participant flow numbers right up
to participant recruitment. Forty-one (73%) studies were
published after the CONSORT statement in 2001. Better
reporting of participant flow was seen in studies published
in and after 2001 in comparison to studies published be-
fore 2001, ‘numbers of potential participants identified’
9/41 (22%) vs. 0/15 (0%) (Fisher’s exact test P = 0.094);
‘numbers assessed for eligibility’ 18/41 (44%) vs. 4/15
(27%) (chi-squared = 1.37, df = 1, P = 0.24) and ‘numbers
eligible’ 33/41 (80%) vs. 10/15 (67%) (chi-squared = 1.18,
df = 1, P = 0.28).
Based on the data available, we were able to calculate
SPRs for 43 studies. Half of the highest value in the
range of proportions for SPR, SDR and IDR was taken
as a cutoff value to show studies with participation rates
above or below the chosen cutoff value. The SPR
amongst studies of PR programmes ranged from 35 to
100% (that is, a cutoff value of 50%), only three (14%)
studies having less than 50% SPR. In studies of SM pro-
grammes, SPR ranged from 23 to 100%, with four (21%)
studies having less than 50% SPR. And amongst the
three studies of HE programmes, SPR was 43%, 73% and
92%. Altogether for 43 studies (21 PR, 19 SM, and 3 HE)
the SPR was less than 50% for only 8 (19%) studies with
12 (34%) studies reporting SPR of 100% (9 PR and 3 SM).
We calculated SDR for all 56 studies and IDR for all
studies except for the two before-after studies (here the re-
sult of IDR and SDR was the same). Amongst PR studies,
study dropout rates ranged from 0 to 59% (that is, cutoff
value of 30%) with 27 (87%) studies having SDR of less
than or equal to 30%. For studies of SM and HE pro-
grammes, the SDR ranged from 0 to 30% and from 11 to
21%. Overall, 52 (93%) studies had an SDR of less than or
equal to 30%.
The IDR amongst studies of PR programmes ranged
from 0 to 54%, 30 (97%) studies having IDR of less than
or equal to 30%. Amongst studies of SM programmes,
IDR ranged from 0 to 60% (that is, a cutoff value of 30%),
18/20 (90%) studies having less than 30% IDR. And in
studies of HE programmes IDR ranged from 7 to 29%.
Overall, IDR for 51/54 (94%) studies was less than or
equal to 30%.
Although we were able to calculate the SDR and IDR,
it was difficult to identify and differentiate between the
number of participants who were lost to follow-up and
participants who discontinued the intervention. We
assumed that participants who dropped out of the study
also dropped out of the intervention unless papers expli-
citly stated otherwise.
As SPR was calculated for 43 studies, 31/43 (72%) stud-
ies with SPR of >50%, had SDR of ≤30%. However, no
obvious pattern could be deduced as 26/31 (84%) studies
had not reported on participant flow data (‘potential parti-
cipants identified’ and/or ‘numbers assessed for eligibility)
before recruitment (Additional file 2).
In the analysis of study characteristics, there was no
evidence for effects of year of publication, study quality,
exercise vs. non-exercise, and group vs. individual treat-
ment on participation rate (Table 1). Figure 4 illustrates
how year of publication had no effect on participation
rate. Confidence intervals for effects were wide, and did
not rule out the possibility of a five-fold increase in the
odds of participation in exercise vs. non-exercise inter
ventions, or a five-fold decrease in group vs. individual
interventions.
Discussion
Principal findings
Our review provides information on how randomised
and non-randomised studies, including before-after stud-
ies, of interventions that help to improve SM in patients
with COPD, report participant flow and the actual
‘participation rates’ amongst these studies. The reporting
of participant flow amongst studies of the two main
interventions (PR and SM) was generally incomplete but
better reporting was seen in studies published in and
after 2001 (the publication year of the CONSORT
Table 1 Odds ratios for participation according to study characteristics
Variable Odds ratio (95% confidence interval) P
Year 0.99 (0.92, 1.08) 0.891
Quality score 0.85 (0.65, 1.10) 0.215
Exercise intervention 1.55 (0.47, 5.07) 0.470
Group intervention 0.506 (trend)
Individual 1.00 -
Combination 0.17 (0.03, 0.81)
Group 0.60 (0.17, 2.11)
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statement). Only 16% of studies reported ‘potential parti-
cipants identified’, and slightly more than a third (39%)
reported ‘numbers assessed for eligibility’. ‘Numbers
eligible’ was better reported amongst studies (77%) but
only seven (13%) studies reported on all levels of the par-
ticipant flow before patient recruitment.
The SPR was not calculated for 13 (23%) studies due
to lack of information on ‘numbers eligible’ for study.
The SPR for the remaining 43 studies was higher than
expected. Only eight (19%) studies had an SPR of less
than 50%. Another unexpected finding was that 93% and
94% of the studies had an SDR and an IDR, respectively,
of less than or equal to 30%. However, it was tricky to
differentiate between ‘numbers lost to follow-up’ and
‘numbers discontinued intervention’. In addition, 31
(72%) of 43 studies with SPR of >50%, had SDR of ≤30%
but no obvious pattern could be deduced because of the
lack of reporting on participant flow data from 26 (84%)
of the 31 studies.
Comparison with other literature
Some studies of both pharmacological and non-
pharmacological interventions and surgical interventions,
have examined reporting of participant flow diagrams
(CONSORT statement recommended) including type of
information within the diagrams, in published studies
identified from a single electronic database [37], in six
high-quality [38] and four high-impact journals [39], with
most journals endorsing the CONSORT reporting of
participant flow [37]. These studies concluded that par-
ticipant flow was poorly reported. In Toerien’s study [38]
40% of studies failed to report ‘numbers assessed for eli-
gibility’. Meanwhile, only 39% of studies in our review
reported ‘numbers assessed for eligibility’ but our study
selection was not based on the quality of the journal. We
found low reporting at this level of participant flow in
studies perhaps because studies did not think it import-
ant to record numbers for external validity, they might
not have considered that patients are part of the trial at
that level or before randomisation and hence failed to
record and report numbers at this level [38,40]. It has
been acknowledged that studies of PR programmes do
not include details or discuss adequately ‘numbers
assessed for eligibility’ nor the refusal rate [15,25].
Regarding reporting ‘numbers of potential participants
identified’ the aforementioned studies did not look at
this level (this level is not included in the CONSORT
flow diagram). A drawback of strictly designed RCTs
may be limited generalisability as the focus is often to
have homogenous groups of patients to limit individual
variation [41]. A recent literature review [15] of PR pro-
grammes looked at reporting of sample selection in
studies of PR programmes and only 12% of studies had
0.0% 20.0% 40.0% 60.0% 80.0%100.0%
Howland 1986
Cockcroft 1987
Littlejohn 1991
Goldstein 1994
Ries 1995
Sassi-Dambron 1995
Strijbos 1996
Emery 1998
Guell 2000
Ringbaek 2000
Finnerty 2001
White 2002
Bourbeau 2003
de Godoy 2003
Monninkhof 2003
Oh 2003
Kara 2004
Man 2004
Rea 2004
Coultas 2005
Lindsay 2005
Na 2005
Casas 2006
Resqueti 2007
Barakat 2008
Efraimsson 2008
Kheirabadi 2008
Nyugen 2008
Sridhar 2008
Carr 2009
Effing 2009
Khdour 2009
Moore 2009
Taylor 2009
Theander 2009
van Wetering  2009
Ghanem 2010
Hill 2010
Lemmens 2010
Liddell 2010
Rice 2010
Ninot 2011
Zakrisson 2011
Participation rate
SM
HE
PR
Figure 4 Participation rates in different studies ordered by year
of publication, and according to type of intervention: self
management (SM), health education (HE), and pulmonary
rehabilitation (PR). Error bars show 95% confidence interval.
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reported the number of people contacted for the study.
In our review, the proportion of studies that reported at
this level was slightly higher (16%). Bjoernshave [15]
explained the lack of recording at this level was because
people with COPD are not normally recruited from
prevalence studies as prevalence of COPD is difficult to
estimate and recruitment normally takes place from
clinics or outpatient settings. Nevertheless, if we at-
tempt to record the total number of patients registered
at a recruitment site ‘denominator’, this data can be
utilised to help generalise the study findings to the tar-
get group [35].
Gross’s review [39] review found that only 43% of
studies had reported ‘numbers eligible’. In our review,
more studies had reported this (77%) perhaps because
most of the studies were published in and after 2001.
With numbers at this level and numbers recruited we
were able to calculate the SPR, SDR and IDR and iden-
tify the actual patient ‘participation rates’ in studies of
PR, SM and HE programmes for COPD patients. Only
Keating’s [19] review has explored patient non-attendance
and non-completion, but only in PR programmes and the
reported proportions were from a mix of quantitative and
qualitative studies. A cutoff value of 20% for SDR is
regarded as acceptable according to a quality assessment
checklist [42]. And less than a third (29%) of studies in
our review had a SDR of >20%, which suggests that most
studies in our review would have fulfilled this particular
quality criterion. Similarly to other studies [37,38] we too
experienced problems in clearly identifying or differenti-
ating between reports of ‘numbers lost to follow-up’ and
‘numbers discontinued intervention’. A distinction needs
to be made between these two types of attrition [40] to
inform on implementation of interventions.
Based on our findings, previous reports of poor partici-
pation and retention in studies of PR and SM programmes
[17-20] might not be justified. One explanation could be
studies having different definitions for patient participa-
tion and thus the method of calculation of participation
rates may have differed [17,26] or not having clear defini-
tions making it difficult to identify if the proportions refer
to the study or intervention [18]. Recent reviews [19,38]
acknowledged that their studies gave varying definitions
for ‘loss to follow-up’ and ‘non-completion’. Examples
here show discrepancies in reports of participation rates:
two studies [21,22] in our review (Additional file 2) had
high SPRs of 71% and 93%, respectively but Young [25]
reported, SPR of 34% and 36% for these two studies. On
investigation it appears that Young calculated SPR from
‘numbers assessed for eligibility’ and not ‘numbers eligible’;
Another study in our review [23] (Additional file 2) had
a SDR of 29% and IDR of 18% respectively but Sabit [24]
reported a dropout rate of 30% and it is unclear whether
the proportion refers to the study or intervention.
Limitations
We tried to identify numbers reported at each level of the
participant flow from effectiveness studies. These studies
may have decided to give more importance towards
recording and reporting numbers for internal validity – a
key feature of strictly designed or high-quality RCTs [41]
rather than external validity. This finding is also acknowl-
edged by the new Medical Research Council guidance on
evaluation of complex interventions [43]. We need to be
cautious of our findings of high participation rates as only
a minority of studies reported on all levels of participant
flow before recruitment and in some cases 100% of eli-
gible patients were recruited without providing the whole
recruitment picture.
Implications for practice
Based on our findings of high study participation rates
and low dropout rates in research studies of PR, SM
and HE programmes, we would strongly endorse the
active implementation of PR and SM programmes in
routine care as patients with COPD are participating,
attending and completing them. Despite notable evi-
dence of benefit from studies of PR programmes [44]
and some benefit from studies of SM programmes
[16], in practice these programmes do not seem to be
widely implemented or some actively running ones are
closing down (Kennedy A. Personal Communication)
thus reducing opportunities for patients who are suitable
to attend and gain benefits from them. We also recom-
mend that future research studies provide clear definitions
when reporting patient participation, enabling a true esti-
mate of patient ‘participation rates’ and avoiding confusion
amongst readers.
To calculate ‘participation rates’, it is important for
studies of PR, SM and HE programmes, to provide more
information on patient participant flow. Incomplete
reporting of patient recruitment data will affect external
validity [15]. It is essential for studies to report these
data to help health care professionals interpret the study
results and to decide if the results could be applied to
their patients [38,39].
Much focus on the implementation of non-
pharmacological interventions has resulted in a shift,
from conducting explanatory trials to pragmatic trials
[41]. One of the features of pragmatic trials is that they
tend to recruit a heterogeneous patient group all with
the condition of interest to maximise the trial results to
usual care settings [45]. To record and report a clear pic-
ture of the recruitment process, studies can utilise the
checklist provided by extension of the CONSORT state-
ment for reporting pragmatic trials [33]. Gross [39]
stressed that studies should at least record and report
‘numbers eligible’ for recruitment. The addition of sev-
eral boxes to the CONSORT flow diagram, before and
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after randomisation, has been recommended by Toerin
[38], which may help to get a better assessment of gener-
alisability, estimate a true non-participation rate, and to
establish a true intervention effect.
Conclusions
This systematic review has identified the actual levels
of participation and dropout rates in research studies
evaluating PR, SM and HE programmes for COPD
patients. These studies should consider recording and
reporting participant flow numbers more completely.
Only 19% of studies had SPR of less than 50%. The
SDR and IDR was less than or equal to 30% in the
vast majority of studies. These findings negate previ-
ous reports of poor participation and retention in
studies of PR and SM programmes. Possible explana-
tions include studies using their own definitions for
what constitutes patient participation in both the
study and the intervention within the study, or stud-
ies, not stating definitions clearly, making it difficult
to identify whether proportions reported refer to the
study or intervention. Clear and uniform definitions
will help to identify a valid estimate of patient partici-
pation rates in the study and the intervention and
could promote the correct interpretation of studies
and the implementation of effective interventions in
routine care.
Endnotes
aIn five studies ‘numbers eligible’ was not clearly stated.
So to calculate SPR in the five studies ‘numbers eligible’
were extracted the following way: reasons reported for not
taking part in the study, between numbers assessed for eli-
gibility and numbers included in study, were reported as
numbers that declined to participate and numbers that
were ineligible for the study. The numbers who declined
to take part were added to numbers included in the study
and were extracted as ‘numbers eligible’.
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